87 related articles for article (PubMed ID: 11789246)
1. [Effect of Saikosaponin-d on up-regulating GR mRNA expression and inhibiting cell growth in human leukemia cells].
Bu S; Xu J; Sun J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 May; 20(5):350-2. PubMed ID: 11789246
[TBL] [Abstract][Full Text] [Related]
2. [Saikosaponin-d up-regulates GR mRNA expression and induces apoptosis in HL-60 cells].
Bu S; Xu J; Sun J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):354-6. PubMed ID: 11721431
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin D acts against corticosterone-induced apoptosis via regulation of mitochondrial GR translocation and a GR-dependent pathway.
Li ZY; Jiang YM; Liu YM; Guo Z; Shen SN; Liu XM; Pan RL
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():80-9. PubMed ID: 24636912
[TBL] [Abstract][Full Text] [Related]
4. Effect of saikosaponin, a triterpene saponin, on apoptosis in lymphocytes: association with c-myc, p53, and bcl-2 mRNA.
Hsu MJ; Cheng JS; Huang HC
Br J Pharmacol; 2000 Dec; 131(7):1285-93. PubMed ID: 11090099
[TBL] [Abstract][Full Text] [Related]
5. The effects of saikosaponin on macrophage functions and lymphocyte proliferation.
Ushio Y; Abe H
Planta Med; 1991 Dec; 57(6):511-4. PubMed ID: 1818339
[TBL] [Abstract][Full Text] [Related]
6. Involvement of p-15(INK4b) and p-16(INK4a) gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells.
Wu WS; Hsu HY
Biochem Biophys Res Commun; 2001 Jul; 285(2):183-7. PubMed ID: 11444823
[TBL] [Abstract][Full Text] [Related]
7. Cell type-oriented differential modulatory actions of saikosaponin-d on growth responses and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed pathways.
Kato M; Pu MY; Isobe K; Hattori T; Yanagita N; Nakashima I
Immunopharmacology; 1995 Apr; 29(3):207-13. PubMed ID: 7622352
[TBL] [Abstract][Full Text] [Related]
8. Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity.
Zong Z; Fujikawa-Yamamoto K; Tanino M; Teraoka K; Yamagishi H; Odashima S
Biochem Biophys Res Commun; 1996 Feb; 219(2):480-5. PubMed ID: 8605013
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of measles virus and herpes simplex virus by saikosaponin d.
Ushio Y; Abe H
Planta Med; 1992 Apr; 58(2):171-3. PubMed ID: 1529029
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the immunoregulatory action of saikosaponin-d.
Kato M; Pu MY; Isobe K; Iwamoto T; Nagase F; Lwin T; Zhang YH; Hattori T; Yanagita N; Nakashima I
Cell Immunol; 1994 Nov; 159(1):15-25. PubMed ID: 7954839
[TBL] [Abstract][Full Text] [Related]
11. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
[No Abstract] [Full Text] [Related]
12. Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity.
Chen L; Zhang F; Kong D; Zhu X; Chen W; Wang A; Zheng S
Chem Biol Interact; 2013 Oct; 206(1):76-82. PubMed ID: 23994742
[TBL] [Abstract][Full Text] [Related]
13. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
Ma X; Dang C; Kang H; Dai Z; Lin S; Guan H; Liu X; Wang X; Hui W
Int Immunopharmacol; 2015 Sep; 28(1):399-408. PubMed ID: 26118633
[TBL] [Abstract][Full Text] [Related]
14. Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway.
Cai C; Zhang H; Ou Y; Jiang Y; Zhong D; Qi H; Dang Q
Neoplasma; 2017; 64(4):518-525. PubMed ID: 28485157
[TBL] [Abstract][Full Text] [Related]
15. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
Hsu YL; Kuo PL; Lin CC
Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811
[TBL] [Abstract][Full Text] [Related]
16. Saikosaponin‑d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase.
Yao M; Yang J; Cao L; Zhang L; Qu S; Gao H
Mol Med Rep; 2014 Jul; 10(1):365-72. PubMed ID: 24736800
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
[TBL] [Abstract][Full Text] [Related]
18. [Effect of saikosaponin-d on rat's glomerular mesangial cell proliferation and extracellular matrix hyperplasia in vitro].
Zu N; Dong X; Fu GX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):321-5. PubMed ID: 17526171
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
Feng R; Shen S; Hui H; Jin M
Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
Hsu YL; Kuo PL; Chiang LC; Lin CC
Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
